ALIVIA HOELTKE: Open Payments
NPI 1154104180 · COLUMBUS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$407 in 17 payments from 9 companies in 2025. Trend: 2023 $86 · 2024 $974 · 2025 $407
Food & beverage: $407
| Company | Payments | Amount |
|---|---|---|
| Fresenius USA Marketing, Inc. | 6 | $126 |
| Stryker Corporation | 2 | $99 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $46 |
| Travere Therapeutics, Inc. | 2 | $31 |
| Vifor Pharma, Inc. | 1 | $25 |
| Apellis Pharmaceuticals, Inc. | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Calliditas Therapeutics US Inc. | 1 | $16 |
Products named: VELPHORO, FLOWTRIEVER CATHETER, S, Kerendia, Veltassa, Empaveli, JYNARQUE, FARXIGA, TARPEYO.
Industry payments across IN — which companies pay providers there.
